Cargando…
Zerumbone Inhibits Helicobacter pylori Urease Activity
Helicobacter pylori (H. pylori) produces urease in order to improve its settlement and growth in the human gastric epithelium. Urease inhibitors likely represent potentially powerful therapeutics for treating H. pylori; however, their instability and toxicity have proven problematic in human clinica...
Autores principales: | Woo, Hyun Jun, Yang, Ji Yeong, Lee, Pyeongjae, Kim, Jong-Bae, Kim, Sa-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124612/ https://www.ncbi.nlm.nih.gov/pubmed/34062878 http://dx.doi.org/10.3390/molecules26092663 |
Ejemplares similares
-
Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation
por: Yang, Ji Yeong, et al.
Publicado: (2021) -
Hesperetin Inhibits Expression of Virulence Factors and Growth of Helicobacter pylori
por: Kim, Hyun Woo, et al.
Publicado: (2021) -
Helicobacter pylori Urease Activity is Influenced by Ferric Uptake Regulator
por: Lee, Jong Seung, et al.
Publicado: (2010) -
Inhibitory Effects of Menadione on Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation via NF-κB Inhibition
por: Lee, Min Ho, et al.
Publicado: (2019) -
New monoclonal antibody-based test for Helicobacter pylori urease in gastric tissue
por: Kim, Do Hyun, et al.
Publicado: (2016)